Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 2,413.95
-5.15 (-0.21%)
At close: Jul 31, 2026
Lupin Employees
Lupin had 26,021 employees as of March 31, 2026. The number of employees increased by 2,015 or 8.39% compared to the previous year.
Employees
26,021
Change (1Y)
2,015
Growth (1Y)
8.39%
Revenue / Employee
10.74M INR
Profits / Employee
2.05M INR
Market Cap
1.10T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 26,021 | 2,015 | 8.39% |
| Mar 31, 2025 | 24,006 | 2,138 | 9.78% |
| Mar 31, 2024 | 21,868 | 935 | 4.47% |
| Mar 31, 2023 | 20,933 | 1,144 | 5.78% |
| Mar 31, 2022 | 19,789 | 1,216 | 6.55% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Torrent Pharmaceuticals | 18,258 |
| J. B. Chemicals & Pharmaceuticals | 5,602 |
| Jubilant Pharmova | 5,547 |
| CORONA Remedies | 5,153 |
| Granules India | 4,306 |
| Caplin Point Laboratories | 3,966 |
| Abbott India | 3,679 |
Lupin News
- 12 days ago - Lupin Transfers Two Oncology Assets To Kaveri Therapeutics - Nasdaq
- 4 weeks ago - Lupin receives EIR from U.S. FDA for Somerset facility with VAI classification - Business Upturn
- 4 weeks ago - Lupin receives EMA approval for NaMuscla expansion for paediatric use - Business Upturn
- 5 weeks ago - Lupin Gets Tentative FDA Nod For Enzalutamide Tablets - Nasdaq
- 5 weeks ago - Lupin Wins FDA's Tentative Approval For Enzalutamide Tablets Across Multiple Strengths - Nasdaq
- 5 weeks ago - Lupin receives tentative approval from U.S. FDA for Enzalutamide tablets - Business Upturn
- 6 weeks ago - Lupin launches Azilsartan Medoxomil Tablets in the United States - Business Upturn
- 7 weeks ago - Lupin collaboraters with Spain’s ERN to launch Luforbec for Asthma and COPD treatment - Business Upturn